CDNA logo

CareDx (CDNA) Company Overview

Profile

Full Name:

CareDx, Inc

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

July 17, 2014

Indexes:

Not included

Website:

http://caredx.com

Description:

CareDx, Inc. is a leading precision medicine company focused on discovering, developing, and commercializing clinically differentiated, high-value medical solutions for transplant patients and caregivers. CareDx, Inc. was founded in 1998 and is headquartered in South San Francisco, California. The company also develops, manufactures, and markets products that increase the likelihood of successful transplantation by facilitating matching between donor and recipient stem cells and organs. Key products of CareDx, Inc. include: - AlloSure Kidney - a cell-free DNA obtained from the donor (dd-cfDNA) solution for kidney transplant patients - AlloMap Heart - a gene expression solution for patients who have undergone heart transplantation.

Key Details

Price

$22.18

Market Cap

$1.19 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$280.32 M(-12.89% YoY)

Annual EPS

-$3.54(-145.83% YoY)

PE Ratio

-

Annual ROE

-54.98%

Annual Debt To Equity

0.00

Beta

1.59

Events Calendar

Earnings

Next earnings date:

Feb 26, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 15, 25 Wells Fargo
Equal-Weight
Jan 14, 25 HC Wainwright & Co.
Neutral
Nov 5, 24 BTIG
Buy
Oct 22, 24 HC Wainwright & Co.
Neutral
Oct 16, 24 Goldman Sachs
Buy
Aug 27, 24 Wells Fargo
Underweight
Aug 19, 24 BTIG
Buy
Aug 1, 24 HC Wainwright & Co.
Neutral
Aug 1, 24 Goldman Sachs
Buy
Aug 1, 24 Craig-Hallum
Buy

Screeners with CDNA included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
Stocks with high beta
Biggest stock losers today
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 3 months
Stocks below analysts price target
Healthcare sector

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$22.18
CDNA price is $22.18

Price All-time High

$95.60
CDNA price is currently -76.80% below its historical high of $95.60

Price Analysts Target

$35.00
CDNA price is currently -36.63% lower than the consensus analysts' forecast

Price Most Recent Change

-5.62%
CDNA price was down -5.62% on Feb 22, 2025

Price YTD Change

+5.27%
CDNA price is up +5.27% since January 1st

Price 3-Year Change

-41.83%
CDNA price is down -41.83% over the past 3 years

Market cap

Market Cap

$1.19 B
CDNA market capitalization is $1.19 billion

Market Cap 3-Year Change

-41.05%
CDNA market capitalization is down -41.05% over the past 3 years

Market Cap All-time High

$4.95 B
CDNA market capitalization is currently -75.97% below its historical high of $4.95 billion

Market Cap Sector Rank

75.85%
CDNA market capitalization is higher than 75.85% of companies in Healthcare sector

Technical

Beta

1.59
CDNA beta is 1.59

200-day SMA

$22.39
CDNA price is currently -0.93% below its 200-day simple moving average

14-day RSI

44.60
CDNA 14-day relative strength index is 44.60

30-day Relative Volume

0.92
CDNA 30-day relative volume is 0.92

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$280.32 M
CDNA annual revenue is $280.32 million

Annual Revenue Analysts Estimate

$332.23 M
CDNA annual revenue is currently -15.62% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-12.89%
CDNA annual revenue is down -12.89% year-on-year

Annual Revenue Sector Rank

68.97%
CDNA annual revenue is higher than 68.97% of companies in Healthcare sector

Profit

Annual Gross Profit

$178.32 M
CDNA annual gross profit is $178.32 million

Annual Gross Margin

63.61%
CDNA annual gross profit margin is 63.61%

Annual Operating Profit

-$104.74 M
CDNA annual operating income is -$104.74 million

Annual Operating Margin

-37.37%
CDNA annual operating profit margin is -37.37%

Annual Net Income

-$190.28 M
CDNA annual net profit is -$190.28 million

Annual Net Margin

-67.88%
CDNA annual net profit margin is -67.88%

EPS

Annual EPS

-$3.54
CDNA annual earnings per share is -$3.54

Annual EPS Analysts Estimate

$0.50
CDNA annual earnings per share is currently -808.00% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-145.83%
CDNA annual earnings per share is down -145.83% year-on-year

Annual EPS Sector Rank

29.5%
CDNA annual earnings per share is higher than 29.5% of companies in Healthcare sector

ROA & ROE

Annual ROA

-37.69%
CDNA annual return on assets is -37.69%

Annual ROE

-54.98%
CDNA annual return on equity is -54.98%

EBIT & EBITDA

Annual EBIT

-$104.74 M
CDNA annual earnings before interest & taxes is -$104.74 million

Annual EBITDA

-$84.92 M
CDNA annual EBITDA is -$84.92 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CDNA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CDNA price to earnings ratio is unknown

PB Ratio

PB Ratio

4.35
CDNA price to book ratio is 4.35

PB Ratio Sector Rank

77.4%
CDNA price to book ratio is higher than 77.4% of companies in Healthcare sector

PS Ratio

PS Ratio

3.80
CDNA price to sales ratio is 3.80

PS Ratio Sector Rank

53.98%
CDNA price to sales ratio is higher than 53.98% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.12 B
CDNA enterprise value is $1.12 billion

Enterprise Value Sector Rank

76.59%
CDNA enterprise value is higher than 76.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-29.12
CDNA EV/EBITDA is -29.12

EV/EBITDA Sector Rank

4.39%
CDNA EV/EBITDA is higher than 4.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.02
CDNA annual current ratio is 4.02

Annual Quick Ratio

3.77
CDNA annual quick ratio is 3.77

Leverage

Annual Debt To Equity

0.00
CDNA annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
CDNA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
CDNA piotroski f-score is 6

Altman Z-Score

1.90
CDNA altman z-score is 1.90

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$466.83 M
CDNA annual total assets is $466.83 million

Annual Non Current Assets

$153.11 M
CDNA annual long term assets is $153.11 million

Annual Current Assets

$313.71 M
CDNA annual total current assets is $313.71 million

Annual Cash & Cash Equivalents

$82.20 M
CDNA annual cash & cash equivalents is $82.20 million

Equity

Annual Book Value

$261.33 M
CDNA annual book value is $261.33 million

Annual Working Capital

$235.64 M
CDNA annual working capital is $235.64 million

Liabilities

Annual Total Liabilities

$205.50 M
CDNA annual total liabilities is $205.50 million

Annual Total Long Term Liabilities

$127.43 M
CDNA annual total long term liabilities is $127.43 million

Annual Current Liabilities

$78.07 M
CDNA annual total current liabilities is $78.07 million

Annual Accounts Payable

$12.87 M
CDNA annual accounts payable is $12.87 million

Debt

Annual Total Debt

$34.22 M
CDNA annual total debt is $34.22 million

Annual Total Debt 1-Year Change

-12.25%
CDNA annual total debt is down -12.25% year-on-year

Annual Long Term Debt

$28.28 M
CDNA annual long term debt is $28.28 million

Annual Short Term Debt

$5.94 M
CDNA annual short term debt is $5.94 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$385.07 M
CDNA annual total expenses is $385.07 million

Annual Operating Expenses

$283.07 M
CDNA annual total operating expenses is $283.07 million

Annual Cost Of Goods Sold

$102.00 M
CDNA annual cost of goods sold is $102.00 million

Annual SGA

$201.20 M
CDNA annual SGA is $201.20 million

Annual D&A

$19.82 M
CDNA annual depreciation & amortization is $19.82 million

Annual Interest Expense

-
CDNA annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$18.39 M
CDNA annual cash flow from operations is -$18.39 million

Annual CFO 1-Year Change

+27.14%
CDNA annual cash flow from operations is up +27.14% year-on-year

Annual CFI

$40.45 M
CDNA annual cash flow from investing activities is $40.45 million

Annual CFI 1-Year Change

+117.7%
CDNA annual cash flow from investing activities is up +117.7% year-on-year

Annual CFF

-$29.61 M
CDNA annual cash flow from financing activities is -$29.61 million

Annual CFF 1-Year Change

-552.83%
CDNA annual cash flow from financing activities is down -552.83% year-on-year

Free CashFlow

Annual FCF

-$27.63 M
CDNA annual free cash flow is -$27.63 million

Annual FCF 1-Year Change

+44.27%
CDNA annual free cash flow is up +44.27% year-on-year

CAPEX

Annual CAPEX

$9.24 M
CDNA annual capital expenditures is $9.24 million

Annual CAPEX 1-Year Change

-62.03%
CDNA annual capital expenditures is down -62.03% year-on-year

Institutional Ownership

Similar stocks

RXST logo
RxSight (RXST)
AORT logo
Artivion (AORT)
RCUS logo
Arcus Biosciences (RCUS)
MDXG logo
MiMedx (MDXG)
ARDX logo
Ardelyx (ARDX)
PCRX logo
Pacira BioSciences (PCRX)
EVH logo
Evolent Health (EVH)
ANIP logo
ANI Pharmaceuticals (ANIP)
ADPT logo
Adaptive Biotechnologies (ADPT)

FAQ

  • What is the ticker symbol for CareDx?
  • Does CareDx pay dividends?
  • What sector is CareDx in?
  • What industry is CareDx in?
  • What country is CareDx based in?
  • When did CareDx go public?
  • Is CareDx in the S&P 500?
  • Is CareDx in the NASDAQ 100?
  • Is CareDx in the Dow Jones?
  • When was CareDx's last earnings report?
  • When does CareDx report earnings?
  • Should I buy CareDx stock now?

What is the ticker symbol for CareDx?

The ticker symbol for CareDx is NASDAQ:CDNA

Does CareDx pay dividends?

No, CareDx does not pay dividends

What sector is CareDx in?

CareDx is in the Healthcare sector

What industry is CareDx in?

CareDx is in the Diagnostics & Research industry

What country is CareDx based in?

CareDx is headquartered in United States

When did CareDx go public?

CareDx's initial public offering (IPO) was on July 17, 2014

Is CareDx in the S&P 500?

No, CareDx is not included in the S&P 500 index

Is CareDx in the NASDAQ 100?

No, CareDx is not included in the NASDAQ 100 index

Is CareDx in the Dow Jones?

No, CareDx is not included in the Dow Jones index

When was CareDx's last earnings report?

CareDx's most recent earnings report was on Nov 4, 2024

When does CareDx report earnings?

The next expected earnings date for CareDx is Feb 26, 2025

Should I buy CareDx stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions